GlaxoSmithKline will pay $3 billion to settle criminal charges

Share this article:

In what is the biggest healthcare fraud settlement in U.S. history, drug maker GlaxoSmithKline will pay $3 billion and plead guilty to illegally promoting prescription drugs. Among other criminal charges brought by the Department of Health and Human Services, GSK pleaded guilty for failing to include safety data about the diabetes drug Avandia in reports to the Food and Drug Administration. According to the Department of Justice, GSK did not disclose post-marketing studies related to Avandia's cardiovascular safety. Since 2007, Avandia has carried black box warnings about the potential increased risk of congestive heart failure, and myocardial infarction, according to court documents. It was pulled from retail pharmacy shelves last year.

Share this article:

More in Products

Malnutrition remains issue

Identifying malnutrition in patients upon admission to a hospital is a low-cost way to improve patient outcomes and reduce readmissions, a new report says. Alleviating Hospital-Based Malnutrition: A Baseline Progress Report is an assessment of hospital-based malnutrition released in connection with the first anniversary of ...

Construction Specialties introduces wall and door protection

Construction Specialties introduces wall and door protection

Construction Specialties Inc. (C/S) has debuted a new line of wall and door protection, Acrovyn by Design and Acrovyn Doors by Design. The products embed high-resolution images and logos as ...

BioSensics launches ActivePERS fall detection

BioSensics launches ActivePERS fall detection

BioSensics has introduced ActivePERS, a personal emergency response and telemonitoring solution for seniors.